Quest Diagnostics (DGX) Shares Outstanding (Weighted Average) (2016 - 2025)
Quest Diagnostics (DGX) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $111.0 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) changed 0.0% to $111.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $111.0 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $111.0 million for FY2025, 0.0% changed from the prior year.
- Shares Outstanding (Weighted Average) hit $111.0 million in Q4 2025 for Quest Diagnostics, down from $112.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $133.0 million in Q1 2021 to a low of $111.0 million in Q1 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $115.8 million across 5 years, with a median of $112.0 million in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 10.53% in 2022 and later rose 0.9% in 2025.
- Year by year, Shares Outstanding (Weighted Average) stood at $125.0 million in 2021, then dropped by 7.2% to $116.0 million in 2022, then fell by 3.45% to $112.0 million in 2023, then dropped by 0.89% to $111.0 million in 2024, then changed by 0.0% to $111.0 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for DGX at $111.0 million in Q4 2025, $112.0 million in Q3 2025, and $112.0 million in Q2 2025.